BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lama J, Buhidma Y, Fletcher E, Duty S. Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research. Neuronal Signaling 2021;5:NS20210026. [DOI: 10.1042/ns20210026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Takakura AC, Moreira TS, Falquetto B. 6-Hydroxydopamine (6-OHDA) rodent model of Parkinson’s disease: Investigating neural control of cardiorespiratory function. Handbook of Animal Models in Neurological Disorders 2023. [DOI: 10.1016/b978-0-323-89833-1.00046-x] [Reference Citation Analysis]
2 S N, Ahmad M, Kumari B, Zainul Ali M, Singh Dholaniya P. Early Diagnosis of Parkinson’s Disease: Utility of Animal Models. Parkinson’s Disease - Animal Models, Current Therapies and Clinical Trials [Working Title] 2022. [DOI: 10.5772/intechopen.107887] [Reference Citation Analysis]
3 Li Y, Yin Q, Wang B, Shen T, Luo W, Liu T. Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment. Front Pharmacol 2022;13:944376. [DOI: 10.3389/fphar.2022.944376] [Reference Citation Analysis]
4 Cunningham T, Stanford C. Introducing a new themed collection on emerging technologies for research models of human neuronal disorders in vivo and in vitro. Neuronal Signaling 2022;6:NS20220065. [DOI: 10.1042/ns20220065] [Reference Citation Analysis]
5 Stetska VО, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine, Dovbynchuk TV, Dziubenko NV, Zholos AV, Tolstanova GM, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine;, Institute of High Technologies, Taras Shevchenko National University of Kyiv, Ukraine;, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Ukraine;, Institute of High Technologies, Taras Shevchenko National University of Kyiv, Ukraine;. Changes in the expression of TRPV4 and TRPM8 channels in the colon of rats with 6-OHDA-induced Parkinson’s disease. Ukr Biochem J 2022;94:57-65. [DOI: 10.15407/ubj94.02.057] [Reference Citation Analysis]
6 Saadullah M, Arif S, Hussain L, Asif M, Khurshid U. Dose Dependent Effects of Breynia cernua Against the Paraquat Induced Parkinsonism like Symptoms in Animals' Model: In Vitro, In Vivo and Mechanistic Studies. Dose Response 2022;20:15593258221125478. [PMID: 36106058 DOI: 10.1177/15593258221125478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Palese F, Pontis S, Realini N, Torrens A, Ahmed F, Assogna F, Pellicano C, Bossù P, Spalletta G, Green K, Piomelli D. Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism. Pharmacol Res 2022;182:106338. [PMID: 35781057 DOI: 10.1016/j.phrs.2022.106338] [Reference Citation Analysis]
8 Brown RE. Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress? The EuroBiotech Journal 2022;6:61-88. [DOI: 10.2478/ebtj-2022-0008] [Reference Citation Analysis]